CARL ICAHN

Real estate mogul Donald Trump and a group of bondholders won control of the three Atlantic City casinos of Trump Entertainment Resorts Inc, a bankruptcy court judge ruled on Monday.

The billionaire investor Carl Icahn has slashed his ownership stake in Blockbuster Inc's Class A shares to below 5 percent, two weeks after the video rental company said it might seek bankruptcy protection and that its survival was in question.

Seven of the world's top hedge fund managers earned 10-figure paychecks and one set a record for the highest-ever payout last year due to a stock market rally that pushed returns to their highest levels in a decade.

Wall Street was poised for a lower open on Wednesday after a report on private-sector employment in March dented hopes of a stronger economic recovery in the United States, and a rating downgrade of Greek banks heightened concerns about the debt-laden country.

Stock index futures pointed to a higher open on Wall Street on Tuesday, with futures for the S&P 500 up 0.14 percent, Dow Jones futures up 0.08 percent and Nasdaq 100 futures up 0.24 percent by 4.01 a.m. ET.

Billionaire investor Carl Icahn said on Monday his $6-a-share offer for Lions Gate Entertainment is fair and that the only reason that the company's stock is trading above $6 is because of him.

Lions Gate Entertainment Corp and Carl Icahn traded angry barbs on Wednesday, one day after the movie studio rejected his hostile bid.

Lions Gate Entertainment Corp's board of directors rejected Carl Icahn's hostile bid to buy the movie studio, calling the offer coercive and too low.

Time Warner Inc, Lions Gate Entertainment Corp and billionaire Len Blavatnik's Access Industries put up rival bids of $1.2 billion to $1.5 billion for studio Metro-Goldwyn-Mayer, sources familiar with the matter, told Reuters on Monday.

Storied Hollywood studio Metro-Goldwyn-Mayer may opt for a stand-alone plan if bids disappoint, and creditors are expected to meet early next week as the company sifts through expected offers, sources said.

Billionaire investor Carl Icahn launched an offer on Friday to buy Lions Gate Entertainment Corp , a move that would hamper the studio's expected bid for storied rival Metro-Goldwyn-Mayer Inc .

Lions Gate Entertainment Corp on Friday said it rejected activist investor Carl Icahn's unsolicited bid to increase his share in the Independent movie studio.

Lions Gate Entertainment Corp said on Monday its board will review activist investor Carl Icahn's unsolicited bid to increase his share in the company.

Celebrity real estate developer Donald Trump, optimistic about a casino comeback, took the stand in U.S. bankruptcy court on Thursday to fight for control of the three Atlantic City hotel-casinos bearing his name.

Celebrity real estate developer Donald Trump and investor Carl Icahn took their fight for the Atlantic City hotel-casinos bearing Trump's name to U.S. bankruptcy court on Tuesday.

Auto parts maker Federal-Mogul Corp (FDML.O) reported a better-than-expected quarterly profit on Tuesday, compared with a year-earlier loss, driven by aggressive cost-cutting and improving global auto production.

Billionaire investor Carl Icahn plans to nominate himself and three others to the board of Genzyme Corp , which is struggling to recover from a manufacturing crisis that lead to shortages of two of its life-saving drugs and sparked outrage from patients and investors alike.

Carl Icahn on Tuesday launched a tender offer to buy control of Lions Gate Entertainment Corp, potentially triggering a technical default in the studio's bank credit facility.

Video game makers should begin to emerge in 2010 from one of their worst industry downturns on record, but investors remain cautious about a sector that has been plagued by bad news.

Biogen Idec Inc said on Thursday it has received notice from billionaire investor Carl Icahn that he intends to nominate three people to its board as he seeks to expand his influence at one of the world's biggest biotech companies.

Proxy materials have been delivered to Biogen Idec Inc by Carl Icahn, as the billionaire investor seeks greater control of the biotechnology company's board, according to a source familiar with the situation.